We've just witnessed the fall of an ASX dividend aristocrat

Ramsay Health Care Limited (ASX: RHC) is now out of the running to be an ASX dividend aristocrat, at least until 2046. Here's why.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Over in the US, the term 'dividend aristocrat' is one that every investor knows.

It refers to a dividend-paying share that has increased said dividend non-stop for at least 25 years in a row.

Here in Australia, the term is less well known. Why? Because (as hard as it is to believe here in the land of franking credits) we simply don't have any.

And dividend kings – the stocks with a 50-year history of dividend raises? Nothing more than a regal legend on the ASX boards.

However, we do have some ASX shares that are getting close to true 'dividend aristocrat' status.

Take Washington H. Soul Pattinson and Co Ltd (ASX: SOL). Soul Patts has just increased its dividend for the 20th year in a row. 5 more and it will be crowned the ASX's first dividend aristocrat.

Unfortunately, this week, we lost another contender.

Ramsay Health Care Limited (ASX: RHC) had a dividend history to rival that of Soul Patts – delivering a dividend increase annually since 2000.

Until Monday.

ASX dividend aristocrat no more

Tragically, Ramsay will be starting from zero in 2021 after it announced its dividends will be suspended for the remainder of 2020.

The company has already paid an interim dividend in March. But if it doesn't pay a final dividend in 2020 (like it's told us it won't) the 20-year streak will come to an end.

Now, Ramsay must have broken its streak because it absolutely had to. We can gather from the ASX release (in which a capital raising was also announced) that its current cash flows have been so severely impacted by the coronavirus that there simply isn't the money there to fund dividend payments for ordinary shares.

But still, this is a sad week for Ramsay Health Care and its shareholders. The list of potential ASX dividend aristocrats grows thin indeed. After Ramsay, I'm watching Brickworks Limited (ASX: BKW) in this space. It's not far behind Soul Patts for dividend longevity. But who knows, maybe in 2046 Ramsay Health Care might finally wear that coveted crown.

Foolish takeaway

Even though I'm bitterly disappointed about this news from Ramsay, I'm still bullish on the long-term future of this company. It has a large network of impeccably-run private hospitals, both in Australia and across several other countries.

Healthcare is an 'evergreen' industry that will only benefit from the ageing population demographics across advanced economies well into the future.

Motley Fool contributor Sebastian Bowen owns shares of Ramsay Health Care Limited and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia owns shares of and has recommended Brickworks and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Female scientist working in a laboratory.
Healthcare Shares

Early success in battling Crohn's Disease has sent this ASX biotech's shares soaring

The early-stage results have been described as outstanding.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

Why are 4DMedical shares in a trading halt today?

The company is looking to raise fresh capital.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX biotech's shares are up strongly on good news out of the US

The addressable market for this newly approved software is huge.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

Which biotech company's shares have rocketed to a new high on good news?

A key US approval is great news for this company.

Read more »

Health professional working on his laptop.
Healthcare Shares

Insiders are buying. Can Pro Medicus shares finally turn the corner?

Insider buying puts Pro Medicus shares in focus after steep pullback, raising questions about downside risk and upside potential.

Read more »

a young boy in profile shows the cochlear implant devide fitted to his ear and attached to the side of his head to help him to process sounds.
Healthcare Shares

Cochlear shares lag the ASX 200 after a tough year. Is it time to buy?

Investors continue to question valuation and wait for stronger earnings momentum.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Healthcare Shares

Why are Mesoblast shares jumping 10% to a 52-week high?

This biotech is hitting new highs on Friday. Let's find out why.

Read more »

a group of surgeons in full surgery dress including masks, gloves and head coverings stands together with arms folded and smiling eyes as if happy with the outcome of their efforts.
Healthcare Shares

Ansell shares tumble to a 3-month low. Is this a buying opportunity?

Ansell shares have slid to a 3-month low. Could oversold signals point to a buying opportunity for long-term investors?

Read more »